Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.

PubWeight™: 2.70‹?› | Rank: Top 1%

🔗 View Article (PMC 4030103)

Published in Diabetes on December 02, 2013

Authors

Antigone S Dimas1, Vasiliki Lagou2, Adam Barker3, Joshua W Knowles4, Reedik Mägi5, Marie-France Hivert6, Andrea Benazzo7, Denis Rybin8, Anne U Jackson9, Heather M Stringham9, Ci Song10, Antje Fischer-Rosinsky11, Trine Welløv Boesgaard12, Niels Grarup13, Fahim A Abbasi4, Themistocles L Assimes4, Ke Hao14, Xia Yang15, Cécile Lecoeur16, Inês Barroso17, Lori L Bonnycastle18, Yvonne Böttcher19, Suzannah Bumpstead20, Peter S Chines18, Michael R Erdos18, Jurgen Graessler21, Peter Kovacs22, Mario A Morken18, Narisu Narisu18, Felicity Payne20, Alena Stancakova23, Amy J Swift18, Anke Tönjes24, Stefan R Bornstein21, Stéphane Cauchi16, Philippe Froguel25, David Meyre26, Peter E H Schwarz21, Hans-Ulrich Häring27, Ulf Smith28, Michael Boehnke9, Richard N Bergman29, Francis S Collins18, Karen L Mohlke30, Jaakko Tuomilehto31, Thomas Quertemous4, Lars Lind32, Torben Hansen33, Oluf Pedersen34, Mark Walker35, Andreas F H Pfeiffer36, Joachim Spranger11, Michael Stumvoll24, James B Meigs37, Nicholas J Wareham3, Johanna Kuusisto23, Markku Laakso23, Claudia Langenberg3, Josée Dupuis38, Richard M Watanabe39, Jose C Florez40, Erik Ingelsson41, Mark I McCarthy42, Inga Prokopenko43, MAGIC Investigators

Author Affiliations

1: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Alexander Fleming, Biomedical Sciences Research Center, Vari, Athens, Greece.
2: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.
3: Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
4: Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA.
5: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.Estonian Genome Center, University of Tartu, Tartu, Estonia.
6: Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, CanadaGeneral Medicine Division, Massachusetts General Hospital, Boston, MA.
7: Department of Biology and Evolution, University of Ferrara, Ferrara, Italy.
8: Boston University Data Coordinating Center, Boston, MA.
9: Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI.
10: Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, SwedenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
11: Charité-Universitätsmedizin Berlin, Department of Endocrinology and Metabolism, Berlin, Germany.
12: Steno Diabetes Center, Gentofte, Denmark.
13: The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
14: Department of Genetics and Genomic Sciences, Institute of Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, NY.
15: Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA.
16: CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, France.
17: Wellcome Trust Sanger Institute, Hinxton, U.K.University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
18: Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
19: IFB AdiposityDiseases, Leipzig University Medical Center, Leipzig, Germany.
20: Wellcome Trust Sanger Institute, Hinxton, U.K.
21: Department of Medicine III, Division of Prevention and Care of Diabetes, University of Dresden, Dresden, Germany.
22: Interdisciplinary Center for Clinical Research Leipzig, Leipzig, Germany.
23: Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
24: IFB AdiposityDiseases, Leipzig University Medical Center, Leipzig, GermanyDepartment of Medicine, University of Leipzig, Leipzig, Germany.
25: CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, FranceDepartment of Genomics of Common Disease, Imperial College London, London, U.K.
26: CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, FranceDepartment of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
27: Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany.
28: Lundberg Laboratory for Diabetes Research, Center of Excellence for Metabolic and Cardiovascular Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
29: Department of Physiology & Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA.
30: Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
31: Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, FinlandCentre for Vascular Prevention, Danube University Krems, Krems, AustriaKing Abdulaziz University, Jeddah, Saudi Arabia.
32: Department of Medical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden.
33: The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkFaculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
34: The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkHagedorn Research Institute, Copenhagen, DenmarkInstitute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, DenmarkFaculty of Health Sciences, University of Aarhus, Aarhus, Denmark.
35: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K.
36: Charité-Universitätsmedizin Berlin, Department of Endocrinology and Metabolism, Berlin, GermanyDepartment of Clinical Nutrition, German Institute of Human Nutrition, Nuthetal, Germany.
37: General Medicine Division, Massachusetts General Hospital, Boston, MADepartment of Medicine, Harvard Medical School, Boston, MA.
38: Department of Biostatistics, Boston University School of Public Health, Boston, MAThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA.
39: Departments of Preventive Medicine and Physiology & Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA.
40: Department of Medicine, Harvard Medical School, Boston, MACenter for Human Genetic Research and Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston, MAProgram in Medical and Population Genetics, Broad Institute, Cambridge, MA.
41: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
42: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, U.K.
43: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.Department of Genomics of Common Disease, Imperial College London, London, U.K.

Articles citing this

Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes (2014) 2.52

Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes (2014) 1.77

Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A (2014) 1.40

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet (2015) 1.39

Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity. Diabetes (2014) 1.26

Recent advances in understanding the genetic architecture of type 2 diabetes. Hum Mol Genet (2015) 1.16

Zinc transporter 8 (ZnT8) and β cell function. Trends Endocrinol Metab (2014) 1.14

Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors. PLoS Genet (2015) 1.03

Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst (2015) 0.98

A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun (2015) 0.97

Susceptibility to type 2 diabetes mellitus--from genes to prevention. Nat Rev Endocrinol (2014) 0.94

Inflammation, metaflammation and immunometabolic disorders. Nature (2017) 0.93

Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk. Diabetologia (2014) 0.90

Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet (2014) 0.89

An integrated cell purification and genomics strategy reveals multiple regulators of pancreas development. PLoS Genet (2014) 0.87

Genome-wide associations for birth weight and correlations with adult disease. Nature (2016) 0.87

Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1. Mol Metab (2014) 0.85

Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes (2015) 0.85

BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization. Diabetes (2016) 0.84

Association of the ACTN3 R577X polymorphism with glucose tolerance and gene expression of sarcomeric proteins in human skeletal muscle. Physiol Rep (2015) 0.83

Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet (2016) 0.82

Association of variants in CDKN2A/2B and CDKAL1 genes with gestational insulin sensitivity and disposition in pregnant Han Chinese women. J Diabetes Investig (2015) 0.81

Protective alleles and modifier variants in human health and disease. Nat Rev Genet (2015) 0.81

Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism (2015) 0.80

Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants. Diabetes (2016) 0.80

Topological analysis of metabolic networks integrating co-segregating transcriptomes and metabolomes in type 2 diabetic rat congenic series. Genome Med (2016) 0.80

The pancreatic β cell: recent insights from human genetics. Trends Endocrinol Metab (2014) 0.80

Using Drosophila to discover mechanisms underlying type 2 diabetes. Dis Model Mech (2016) 0.80

Evaluation of type 2 diabetes genetic risk variants in Chinese adults: findings from 93,000 individuals from the China Kadoorie Biobank. Diabetologia (2016) 0.80

The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice. Diabetologia (2015) 0.79

A cautionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1. Diabetologia (2015) 0.79

An epidemiological perspective of personalized medicine: the Estonian experience. J Intern Med (2015) 0.78

The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes. Front Endocrinol (Lausanne) (2015) 0.78

Genetics of Insulin Resistance and the Metabolic Syndrome. Curr Cardiol Rep (2016) 0.78

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes (2017) 0.78

10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet (2017) 0.78

Insights into islet development and biology through characterization of a human iPSC-derived endocrine pancreas model. Islets (2016) 0.77

The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions. Environ Health Perspect (2016) 0.77

Insulin-degrading enzyme inhibition, a novel therapy for type 2 diabetes? Cell Metab (2014) 0.77

Physiology helps GWAS take a step closer to mechanism. Diabetes (2014) 0.77

Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring. JAMA Pediatr (2015) 0.77

Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants. Diabetes (2015) 0.77

Mechanisms of Type 2 Diabetes Risk Loci. Curr Diab Rep (2017) 0.76

MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women. Int J Endocrinol (2014) 0.76

Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? BMC Biol (2015) 0.76

The Importance of Context: Uncovering Species- and Tissue-Specific Effects of Genetic Risk Variants for Type 2 Diabetes. Front Endocrinol (Lausanne) (2016) 0.76

Risk Alleles in/near ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2 Elevate Plasma Glucose Levels at Birth and in Early Childhood: Results from the FAMILY Study. PLoS One (2016) 0.76

Islet biology, the CDKN2A/B locus and type 2 diabetes risk. Diabetologia (2016) 0.76

Assignment of Functional Relevance to Genes at Type 2 Diabetes-Associated Loci Through Investigation of β-Cell Mass Deficits. Mol Endocrinol (2016) 0.76

Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes (2016) 0.76

Polymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic Risk Scores. Nutrients (2016) 0.75

Polymorphisms in Four Genes (KCNQ1 rs151290, KLF14 rs972283, GCKR rs780094 and MTNR1B rs10830963) and Their Correlation with Type 2 Diabetes Mellitus in Han Chinese in Henan Province, China. Int J Environ Res Public Health (2016) 0.75

Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol (2017) 0.75

Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice. Am J Hum Genet (2017) 0.75

Human genetics as a model for target validation: finding new therapies for diabetes. Diabetologia (2017) 0.75

Transcriptional Regulation of the Pancreatic Islet: Implications for Islet Function. Curr Diab Rep (2015) 0.75

Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease. Physiology (Bethesda) (2017) 0.75

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes. Diabetes Care (2016) 0.75

CDC123/CAMK1D gene rs12779790 polymorphism and rs10811661 polymorphism upstream of the CDKN2A/2B gene in women with gestational diabetes. J Perinatol (2017) 0.75

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology. F1000Res (2016) 0.75

Erchen Decoction Prevents High-Fat Diet Induced Metabolic Disorders in C57BL/6 Mice. Evid Based Complement Alternat Med (2015) 0.75

Allelic expression imbalance: tipping the scales to elucidate the function of type 2 diabetes-associated loci. Diabetes (2015) 0.75

How Can Genetic Studies Help Us to Understand Links Between Birth Weight and Type 2 Diabetes? Curr Diab Rep (2017) 0.75

The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases. J Lipid Res (2017) 0.75

Molecular correlates of fat mass expansion in C57BL/6J mice after short-term exposure to dietary fat. Ann N Y Acad Sci (2015) 0.75

Painting a new picture of personalised medicine for diabetes. Diabetologia (2017) 0.75

Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk. Rev Diabet Stud (2016) 0.75

Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat Genet (2017) 0.75

A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants. Diabetes (2017) 0.75

Prioritising Causal Genes at Type 2 Diabetes Risk Loci. Curr Diab Rep (2017) 0.75

Type 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics. Rev Diabet Stud (2016) 0.75

Mining the Genome for Therapeutic Targets. Diabetes (2017) 0.75

Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development. Curr Diab Rep (2017) 0.75

An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus? Diabetologia (2016) 0.75

Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study. Diabetologia (2017) 0.75

Articles cited by this

A haplotype map of the human genome. Nature (2005) 105.70

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care (1999) 26.39

METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 21.21

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Type 2 diabetes: principles of pathogenesis and therapy. Lancet (2005) 10.71

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med (2004) 8.62

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med (2001) 6.79

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet (2007) 5.88

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet (2008) 4.84

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care (2000) 4.14

GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics (2010) 4.11

Diabetes mellitus and genetically programmed defects in beta-cell function. Nature (2001) 3.51

Diabetes mellitus and the β cell: the last ten years. Cell (2012) 3.31

Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet (2011) 3.20

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract (2000) 3.13

The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci (2010) 3.09

Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia (2008) 2.65

Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia (2008) 2.57

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21

TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes (2007) 2.20

How to measure insulin sensitivity. J Hypertens (1998) 1.96

Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes (2002) 1.72

The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med (2013) 1.70

Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes (2009) 1.44

TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia (2009) 1.33

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab (1998) 1.29

Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia (2009) 1.13

Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. Diabetologia (2008) 1.09

Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans. Diabetes (2013) 1.02

Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS One (2011) 0.98

Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun (2000) 0.94

The diabetogenic VPS13C/C2CD4A/C2CD4B rs7172432 variant impairs glucose-stimulated insulin response in 5,722 non-diabetic Danish individuals. Diabetologia (2011) 0.93

Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release. Diabetologia (2011) 0.91

The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals. BMC Med Genet (2012) 0.83

Articles by these authors

Genetic studies of body mass index yield new insights for obesity biology. Nature (2015) 8.27

The Lin28/let-7 axis regulates glucose metabolism. Cell (2011) 4.65

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92

New genetic loci link adipose and insulin biology to body fat distribution. Nature (2015) 3.38

Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet (2011) 3.20

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care (2010) 2.14

Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care (2010) 2.06

Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet (2016) 1.90

The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet (2015) 1.87

Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes (2014) 1.77

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study. Cardiovasc Drugs Ther (2011) 1.46

The genetic architecture of type 2 diabetes. Nature (2016) 1.43

Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. Kidney Int (2016) 1.43

Impact of common variation in bone-related genes on type 2 diabetes and related traits. Diabetes (2012) 1.42

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet (2015) 1.39

Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet (2016) 1.22

Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes (2010) 1.20

Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes (2011) 1.13

Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet (2015) 1.08

Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes (2013) 1.06

Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet (2013) 1.04

Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet (2015) 1.02

A central role for GRB10 in regulation of islet function in man. PLoS Genet (2014) 1.01

Racial/ethnic differences in association of fasting glucose-associated genomic loci with fasting glucose, HOMA-B, and impaired fasting glucose in the U.S. adult population. Diabetes Care (2010) 1.01

Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet (2012) 0.99

Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Diabetologia (2013) 0.91

Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases. Eur J Hum Genet (2015) 0.89

Variants in ACAD10 are associated with type 2 diabetes, insulin resistance and lipid oxidation in Pima Indians. Diabetologia (2010) 0.89

Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care (2014) 0.86

Rare and low-frequency coding variants alter human adult height. Nature (2017) 0.85

Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease. PLoS One (2014) 0.84

Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans. PLoS One (2015) 0.83

Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk. Diabetes (2014) 0.83

Variation and association to diabetes in 2000 full mtDNA sequences mined from an exome study in a Danish population. Eur J Hum Genet (2014) 0.81

Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver Int (2015) 0.81

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial. Eur J Heart Fail (2016) 0.81

Eating Behaviour in the General Population: An Analysis of the Factor Structure of the German Version of the Three-Factor-Eating-Questionnaire (TFEQ) and Its Association with the Body Mass Index. PLoS One (2015) 0.80

Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval. Eur Heart J (2015) 0.80

Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults. PLoS Genet (2017) 0.78

The type 2 diabetes risk allele of TMEM154-rs6813195 associates with decreased beta cell function in a study of 6,486 Danes. PLoS One (2015) 0.78

Blood pressure levels in male carriers of Arg82Cys in CD300LG. PLoS One (2014) 0.77

A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study). BMJ Open (2014) 0.76

Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes (2016) 0.76

Genome-wide association studies of human adiposity: Zooming in on synapses. Mol Cell Endocrinol (2015) 0.76

A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes (2017) 0.75

Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations. Diabetes (2016) 0.75

Discovery of novel heart rate-associated loci using the Exome Chip. Hum Mol Genet (2017) 0.75

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. J Am Soc Nephrol (2016) 0.75

Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis. PLoS One (2017) 0.75

A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants. Diabetes (2017) 0.75

Influence of endogenous NEFA on beta cell function in humans. Diabetologia (2015) 0.75

Exome-wide association study of plasma lipids in >300,000 individuals. Nat Genet (2017) 0.75

Gene-diet interaction of a common FADS1 variant with marine polyunsaturated fatty acids for fatty acid composition in plasma and erythrocytes among men. Mol Nutr Food Res (2015) 0.75